World experts and funders set priorities for COVID-19 research
Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo on 12 February 2020
International Day of Women and Girls in Science
Pregnancy and breastfeeding during an Ebola virus outbreak
WHO and FIND formalize strategic collaboration to drive universal access to essential diagnostics
A meeting on digital innovations, TB and implementation research organized by WHO and the European Respiratory Society
Online training as a weapon to fight the new coronavirus
Ministers to agree new global road safety agenda to 2030
WHO to accelerate research and innovation for new coronavirus
The economic cost of female genital mutilation
Female Genital Mutilation Hurts Women and Economies
Unleashing Youth Power: A Decade of Accelerating Actions Towards Zero Female Genital Mutilation
US$675 million needed for new coronavirus preparedness and response global plan
E-cigarettes are harmful to health
WHO EB recommends the adoption of the strategy for elimination of cervical cancer
Delegates welcome the draft immunization vision and strategy and the global strategy to defeat meningitis by 2030
WHO outlines steps to save 7 million lives from cancer
Multiple definitions of infertility
To eliminate cervical cancer in the next 100 years, implementing an effective strategy is critical
Youth and decent work in the health and social care sector
WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time
A tribute to Dr LEE Jong-wook, Director-General of WHO
Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™).
Two-dose presentation of preservative-free Human Papilloma Vaccine from GlaxoSmithKline (GSK) (Cervarix™).
Statement from the Global Advisory Committee on Vaccine Safety
Suspension of Statens Serum Institute IPV supply through UN procurement
Lifting of supply suspension of Inactivated Polio Vaccine (IPV) produced by AJ Vaccines former Statens Serum Institut (SSI)
Notice of Concern (NOC) withdrawn for Cadila Healthcare Ltd
WHO statement on BCG vaccine
WHO Statement on higher than normal incidence of aggregation in Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus Influenzae Type B vaccine, ready to use (liquid) single-dose presentation, produced by Biological E. Limited, India
WHO appoints co-chairs of Independent Commission on sexual misconduct during the Ebola response in North Kivu and Ituri, the Democratic Republic of the Congo
Sixth Annual meeting of the “Friends of the Task Force” Working with Member States to deliver the NCD-related SDG targets during and beyond COVID-19
New electronic survey manual supports countries to combat micronutrient deficiencies
WHO Bulletin Call for Papers: Behavioural and Social Sciences for Better Health
WHO takes a position on genetically modified mosquitoes
RESPECT Implementation package for preventing violence against women
WHO: Global TB progress at risk
Investment in digital health needs careful planning: new WHO guide explains how to do it well
